Ifa Magazine

Anglo American: Bank of America downgrades to neutral.

Aberdeen Asset Management: Peel Hunt raises target to 350p from 300p, reiterates buy.

Dairy Crest: Shore Capital downgrades to hold.

Diploma: Panmure Gordon reiterates buy, takes target up to 500p from 440p.

Filtronic: Panmure Gordon reiterates buy, raises target to 58p from 55p.

Games Workshop: Peel Hunt reiterates buy, ups target to 750p from 700p.

GKN: Investec lowers target to 240p from 245p, reiterates neutral.

Micro Focus Intl.: JP Morgan Cazenove has reiterated their neutral stance, while upping their target to 585p from 381p before hand.

Northgate: UBS downgrades to neutral, but raises target to 250p from 245p.

Petradiamonds: Panmure Gordon reiterates sell.

William Hill: Jefferies reiterates hold, raises target price to 285p from 260p.

William Hill: Alpha Value upgrades to reduce.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold from buy, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy rating retained; Jefferies maintains buy rating and 195p target.

GKN: Credit Suisse raises target from 240p to 245p, outperform rating kept.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

AstraZeneca: UBS ups target from 3,500p to 3,600p, buy rating kept.

Berkeley: Investec raises target from 1,500p to 1,560p, buy rating kept.

Catlin: Nomura reiterates buy rating and 506p target.

Centrica: Deutsche Bank downgrades to hold, target cut from 365p to 320p.

Falkland Oil and Gas: Merchant Securities puts 402p target under review, buy raining kept; Jefferies maintains buy rating and 195p target.

GlaxoSmithKline: UBS cuts target from 1,650p to 1,625p, buy rating unchanged.

IAG: UBS cuts target from 210p to 191p, buy rating kept; Investec maintains buy rating and 190p target; Credit Suisse downgrades to neutral, target cut from 176p to 160p.

InterContinental Hotels: Investec keeps buy rating and 1,700p target.

Prudential: Jefferies lifts target from 817p to 840p, hold rating kept.

RBS: Nomura keeps reduce rating and 260p target.

RSA: UBS cuts target from 103p to 100p, neutral rating kept.

Serco: Panmure Gordon downgrades to hold, 630p target kept.

SSE: Deutsche Bank downgrades to hold, target cut from 1,550p to 1,400p.

Telecity Group: Investec keeps hold rating and 750p target.

Anglo American: Jefferies cuts target from 2,950p to 2,200p, buy rating kept.

Barclays: Nomura reiterates reduce rating and 210p target.

Fidessa: Jefferies keeps hold recommendation and 1,510p target; Merchant Securities maintains buy rating; Investec puts target under review, sell rating kept.

Greene King: Liberum Capital downgrades to hold.

Hammerson: Investec downgrades from hold to sell, target cut from 425p to 415p.

Hiscox: Nomura keeps reduce rating and 431p target.

Kesa Electricals: Investec slashes target from 57p to 36p, hold rating kept.

London Mining: Investec ups target from 267p to 274p, buy rating kept.

National Grid: Investec maintains sell rating and 549p target.

Reckitt Benckiser: Investec keeps hold rating and 3,600p target; Nomura keeps buy rating and 3,900p target.

RSA: Jefferies maintains buy rating and 129p target; Investec keeps hold rating and 102p target; Nomura cuts target from 120p to 118p, neutral rating kept.

Senior: Jefferies raises target from 222p to 223p, buy rating kept.

Spectris: UBS ups target from 1,650p to 1,750p, buy rating kept.

Stagecoach: HSBC upgrades to overweight, target lifted from 250p to 310p.

Travis Perkins: Deutsche Bank downgrades to hold.

UBM: Nomura raises target from 675p to 800p, buy rating kept.

William Hill: UBS ups target from 300p to 315p, buy rating kept.

Abcam: Numis downgrades to add.

Aberdeen Asset Management: Peel Hunt upgrades to buy.

Barclays: Nomura keeps reduce rating and 210p target.

Beazley: Nomura ups target from 147p to 165p, neutral rating kept.

Hammerson: Jefferies maintains buy rating and 487p target.

Home Retail: Numis upgrades to add, target raised from 63p to 85p.

Kingfisher: JPMorgan Cazenove downgrades to neutral.

Lloyds: Nomura reiterates reduce rating and 35p target.

Morgan Crucible: Jefferies downgrades from buy to hold, target cut from 365p to 300p.

Rolls-Royce: UBS ups target from 650p to 750p, sell rating kept.

Senior: Jefferies keeps buy rating and 222p target.

Stagecoach: Jefferies upgrades from hold to buy, target lifted from 240p to 335p.

Travis Perkins: Jefferies cuts target from 1,260p to 1,220p, buy rating kept.

Vodafone: Nomura keeps buy rating and 225p target.

Weir: Jefferies reiterates buy rating and 2,185p target.

Lloyds: Nomura reiterates reduce rating and 35p target.

Royal Bank of Scotland: Nomura reiterates reduce rating and 26p target.

BP: Nomura reiterates neutral rating and 500p target.

Aveva: UBS downgrades from neutral to sell, target lifted from 1,400p to 1,550p.

CSR: finnCap maintains buy rating and 240p target.

BTG: finnCap maintains hold rating and 316p target.

Ladbrokes: UBS ups target from 170p to 175p, buy rating unchanged.

Spectris: UBS raises target from 1,800p to 1,900p, buy rating unchanged.

UBM: UBS downgrades from buy to neutral, target cut from 625p to 610p.

Go-Ahead: UBS upgrades from sell to neutral.

National Express: UBS confirms buy rating and 260p target.

Latest News

e2v technologies expects modest revenue growth
20 May 2013

e2v technologies, a specialist provider of systems and equipment, reported a drop in 2012 earni... Read more

Capita selected as preferred bidder for council contract
20 May 2013

Outsourcing group Capita has been selected as the preferred bidder for a contract with Barnet C... Read more

For professional advisers only

For today's discerning financial
and investment professional

Monday broker round-up:
Posted on: 24 Sep 2012 by Caroline Barton

Related Posts

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 08 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 07 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 06 Aug 2012 by Caroline Barton

Monday broker round-up
Posted on: 30 Jul 2012 by Caroline Barton

Monday broker round-up
Posted on: 23 Jul 2012 by Caroline Barton

Monday broker round-up
Posted on: 20 Feb 2012 by James Farmer

Latest News

e2v technologies expects modest revenue growth
20 May 2013

Capita selected as preferred bidder for council contract
20 May 2013

Quick Links

News

Archive

IFA Magazine

For today's discerning financialand investment professional

Related Posts

Latest News

e2v technologies expects modest revenue growth 20 May 2013

Capita selected as preferred bidder for council contract 20 May 2013

Quick Links

News

Archive

For today's discerning financial
and investment professional

e2v technologies expects modest revenue growth
20 May 2013

Capita selected as preferred bidder for council contract
20 May 2013